Calyxt Reports Record Fourth Quarter and Full Year 2019 Financial Results

Go back to Calyxt Reports Record Fourth Quarter and Full Year 2019 Financial Results

Goldman Sachs Downgrades Calyxt Inc. (CLXT) to Neutral Following Q4 EPS

March 5, 2020 7:15 PM EST

Goldman Sachs analyst Adam Samuelson downgraded Calyxt Inc. (NASDAQ: CLXT) from Buy to Neutral with a price target of $7.00 (from $19.00).

For an analyst ratings summary and ratings history on Calyxt Inc. click here. For more ratings news on Calyxt Inc. click here.

Shares of Calyxt Inc. closed at $6.56 yesterday.

... More

Calyxt (CLXT) Misses Q4 EPS by 4c

March 5, 2020 7:17 AM EST

Calyxt (NASDAQ: CLXT) reported Q4 EPS of ($0.37), $0.04 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.73 million.

Fourth Quarter 2019 Financial Results

Revenue increased to $3.8 million, entirely from increased sales volumes of HO soybean oil and soybean meal. HO soybean oil revenue represented 32 percent of total revenue in the period.Cost of goods sold increased to $5.4 million, reflecting the cost of product sold in the period.Gross margin as reported decreased $1.7 million, reflecting the higher costs we have experienced at... More